Premium
Three‐dimensional printing in a pandemic: panacea or panic?
Author(s) -
Wagels Michael,
Hutmacher Dietmar W
Publication year - 2020
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja2.50753
Subject(s) - library science , panacea (medicine) , citation , computer science , medicine , alternative medicine , pathology
1 The Australian Centre for Complex Integrated Surgical Solutions, Princess Alexandra Hospital, Brisbane, QLD. 2 The University of Queensland, Brisbane, QLD. 3 ARC Centre in Additive Biomanufacturing, Queensland University of Technology, Brisbane, QLD. dietmar.hutmacher@qut.edu.au ▪ doi: 10.5694/mja2.50753 ▪ See Research (Williams). Even before they had to deal with the COVID19 pandemic, clinicians were negotiating the infiltration of threedimensional printing (3DP) into several aspects of medicine. This development probably began with the invention of stereolithography by Charles Hull in 1983.1 The technology has found broad application in engineering and manufacturing, particularly for computeraided design of machine parts. Its principles were also relevant to related aspects of clinical medicine, beginning with the production of reference biomodels from imaging data, and later in virtual surgical planning. It did not take long for the workflow that provided these services in the clinical environment to expand into other areas.